Delivery Order SPE2DB22D2206-SPE2DB26FDR05
Award Date 10/16/25
Potential Completion Date 10/17/25
Potential Value $51K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $14,582.36 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with a completion date of July 31, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, and this delivery order represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $14,102.37 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on September 12, 2025, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used for HIV treatment and...
- The Defense Logistics Agency (DLA) awarded a $35,790.27 delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under the open market. The contract has an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Descovy is an...
- The Defense Logistics Agency awarded a delivery order valued at $4,739.71 to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a pharmaceutical supply delivery from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania to the same location. Descovy is an antiretroviral medication used in...
- The Defense Logistics Agency awarded a $2,842.20 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 16, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $8,812.16 and an ultimate completion date of April 22, 2025. The contract was competitively awarded with no set-aside designation. Descovy is an antiretroviral medication used in HIV treatment and prevention, reflecting the critical pharmaceutical support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,772.57 to AmerisourceBergen Drug Corp for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This non-set-aside, firm fixed price delivery order was awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Descovy is an antiretroviral medication used in HIV prevention and treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Descovy 200-25 mg tablets in quantities of 30 units. This order, valued at $7,045.86 under a firm fixed-price contract type, represents a non-competitive delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be fulfilled at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $8,390.42 firm fixed price delivery order to AmerisourceBergen Drug Corp for 30 units of Descovy 200-25 mg tablets. The award, issued on April 28, 2025, with an ultimate completion date of April 29, 2025, represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. Descovy is an antiretroviral medication used in HIV treatment and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Descovy 200-25 mg tablets (30-count units) with a ceiling value of $11,729.79 under a firm fixed-price contract. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025. This delivery order is not set-aside and represents a competitive award to the prime contractor, whose corporate office is located in Conshohocken, Pennsylvania. Descovy is an antiretroviral...